Sanofi(SNY) - 2024 Q2 - Earnings Call Transcript

Thank you very much Shirley. A few elements in your question. First point, I understood you were questioning on the partnership with Novavax and more specifically about the combination vaccines where we have, you understood very well, we really want to make sure that there is no compromise, neither on safety or efficacy, and we believe that a combination is only worth if you're at least as good or better than the best standalone products separately. That's exactly what we want to do with the combination vac ...